e-SPACE Heart Failure 2022

Published: 19 October 2022

  • Views:

    Views Icon 17616

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

 

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

 

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
 

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1) Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2) Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 5: Managing side effects of HF drugs Watch now
Meet the expert: Sex differences in advanced heart failure Watch now
Plenary Session 6: How to manage the obese patient with HF Watch now

Part 2

Day 2

10 sessions
Plenary Session 7: New technologies to manage your patients Watch now
Meet the expert: Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients (Sponsored by an unrestricted grant from CVRx) Watch now
Plenary Session 8: New technologies to treat your patients Watch now
Plenary Session 9: Comparing European and US recent guidelines Watch now
Satellite Symposim: Bridging the implementation gap in heart failure across the EF spectrum (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 10: How to implement these GLS in ambulatory patients around the world Watch now
Meet the expert: SGLT2 inhibition in patients with HFrEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 11: Managing the HF patient with valvular heart disease Watch now
Meet the expert: Management of tricuspid regurgitation in heart failure (Supported by an unrestricted educational grant from Edwards Lifesciences) Watch now
Plenary Session 12: Managing the patient with worsening and advanced HF Watch now

Faculty Biographies

Maurizio Volterrani

Maurizio Volterrani

Head of the Cardiological Rehabilitation Unit

Full Professor in of Exercise Science and Medicine at San Raffaele Telematic University of Rome. Head of the Cardiac Pulmonary Department at IRCCS San Raffaele in Rome. Prof Volterrani’s main research interests include heart failure, exercise training in cardiac rehabilitation, telemedicine, hyperkalaemia and kidney failure . He is and has been principal investigator in multiple international clinical trials mainly related to heart failure.

He is a Board Member and Fellow of the Heart Failure Association (HFA) of the European Society of Cardiology and holds the following positions:

  • Coordinator the Exercise Physiology and Training Committee of the HFA
  • Coordinator of Endorsement Committee for Higher Educatio of the HFA
  • Co-coordinator of the Registry and Epidemiology Committee of the HFA
  • HFA Liaison officer of the ESC Digital Committee
  • Member of the HFA Study Group on Cachexia, Sarcopenia and Frailty
View full profile
Anja Sandek

Anja Sandek

Dr Anja Sandek works at University Clinic, Goettingen, DE. 

View full profile